PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit!

PRCT INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that PROCEPT BioRobotics Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! NEW YORK CITY, NY / ACCESS Newswire / July 28, 2026 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against PROCEPT BioRobotics Corporation (NASDAQ:PRCT) and certain of its officers.

This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Procept securities between February 28, 2024 and February 25, 2026, both dates inclusive (the "Class Period"). Such investors are encouraged to join this case by visiting the firm's site: bgandg.com/PRCT.

Procept Case Details

The Complaint alleges that throughout the Class Period, Defendants made materially false and/or misleading statements and failed to disclose material adverse facts about the Company's business, operations, and financial condition. Specifically, the Complaint alleges that Defendants failed to disclose to investors:

that Procept used significant discounts to incentivize customers to place bulk orders for its products;

that these discounting practices artificially inflated the Company's current-period revenue by pulling future demand forward, making its reported financial results unsustainable;

that Procept materially overstated the utilization of its handpiece units;

that, as a result, the Company's reported revenue growth, product demand, and utilization metrics did not accurately reflect the underlying performance of its business; and

that, as a result of the foregoing, Defendants' positive statements regarding Procept's business, operations, financial results, and growth prospects were materially false and misleading and/or lacked a reasonable basis.

What's Next for Procept Investors?

A class action lawsuit has already been filed. If you wish to review a copy of the Complaint, you can visit the firm's site: bgandg.com/PRCT. or you may contact Peretz Bronstein, Esq. or his Client Relations Manager, Nathan Miller, of Bronstein, Gewirtz & Grossman, LLC at 917-590-0911. If you suffered a loss in Procept you have until September 22, 2026, to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as lead plaintiff.

No Cost to Procept Investors

We, Bronstein, Gewirtz & Grossman LLC, represent investors in class actions on a contingency fee basis. That means we will ask the court to reimburse us for out-of-pocket expenses and attorneys' fees, usually a percentage of the total recovery, only if we are successful.

Why Bronstein, Gewirtz & Grossman, LLC for Procept Securities Class Action?

Bronstein, Gewirtz & Grossman, LLC is a nationally recognized firm that represents investors in securities fraud class actions and shareholder derivative suits. Our firm has recovered hundreds of millions of dollars for investors nationwide. More at www.bgandg.com

"Our practice centers on restoring investor capital and ensuring corporate accountability, which serves to uphold the essential integrity of the marketplace," said Peretz Bronstein, Founding Partner of Bronstein, Gewirtz & Grossman, LLC.

Contact Info

Peretz Bronstein, Esq. or Nathan Miller

Bronstein, Gewirtz & Grossman, LLC

917-590-0911 | [email protected]

Attorney advertising.

Prior results do not guarantee similar outcomes.

SOURCE: Bronstein, Gewirtz & Grossman, LLC